BioAuxilium Research Inc.

Dr. Jaime Padros and Mireille Caron are the co-founders of BioAuxilium and each have over 20 years of academic and industry experience. They have a renowned expertise in the design, development and manufacturing of assay kits and reagents on the most popular technology platforms available (e.g., TR-FRET, AlphaScreen®/AlphaLISA®, BRET/BRET2, FP, Aequorin and more). Before BioAuxilium, Mireille and Jaime were Technical Project Leaders and Senior Scientists at PerkinElmer-BioSignal (Montréal), where they played key roles in the development of several commercially successful products based on TR-FRET. Since the inception of BioAuxilium in 2013, Mireille and Jaime, supported by their team of scientists, have developed and licensed hundreds of TR-FRET assay kits enabling the quantification of cellular proteins and biomarkers. BioAuxilium is based in Montréal (Canada) and located within NEOMED’s state-of-the-art laboratories and core facilities where the company provides a wide range of product and assay development services to academic and industry research groups.